PM-431 tagged posts

David vs Goliath: How a Small Molecule can defeat Asthma Attacks

Chemical structure of small molecule PM-43I. Credit: Courtesy of D. Corry

Chemical structure of small molecule PM-43I. Credit: Courtesy of D. Corry

Small molecule PM-43I prevented and reversed preexisting allergic airway disease in mice and cleared through the kidneys with no long-term toxicity. Asthma is one of the most common and difficult to endure chronic conditions. About 30 million Americans experience asthma attacks and 3 million have a severe, therapy-resistant form of the disease. In some cases, the condition can be fatal.

“Despite the prevalence of asthma around the world, therapy for this condition has not significantly changed, with a few exceptions, in the last 70 to 80 years,” said Dr. David Corry, professor of medicine-immunology, allergy and rheumatology at Baylor College of Medicine...

Read More